Establishing secure connection… Loading editor… Preparing document…
Navigation

Fill and Sign the Tender Authorization Letter Sample Form

Fill and Sign the Tender Authorization Letter Sample Form

How it works

Open the document and fill out all its fields.
Apply your legally-binding eSignature.
Save and invite other recipients to sign it.

Rate template

4.4
51 votes
RESEARCH ARTICLE 2569 Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18 Michael Hesse1,*, Thomas M. Magin1,* and Klaus Weber2,* 1Institute of Genetics, Division of Molecular Genetics and Bonner Forum Biomedizin, University of Bonn, 53117 2Max-Planck-Institute for Biophysical Chemistry, Department of Biochemistry, 37070 Goettingen, Germany Bonn, Germany *Authors for correspondence (e-mail: t.magin@uni-bonn.de; m.hesse@uni-bonn.de; r.longo@gwdg.de) Accepted 23 May 2001 Journal of Cell Science 114, 2569-2575 (2001) © The Company of Biologists Ltd SUMMARY We screened the draft sequence of the human genome for genes that encode intermediate filament (IF) proteins in general, and keratins in particular. The draft covers nearly all previously established IF genes including the recent cDNA and gene additions, such as pancreatic keratin 23, synemin and the novel muscle protein syncoilin. In the draft, seven novel type II keratins were identified, presumably expressed in the hair follicle/epidermal appendages. In summary, 65 IF genes were detected, placing IF among the 100 largest gene families in humans. All functional keratin genes map to the two known keratin clusters on chromosomes 12 (type II plus keratin 18) and 17 (type I), whereas other IF genes are not clustered. Of the 208 keratin-related DNA sequences, only 49 reflect true keratin genes, whereas the majority describe inactive gene fragments and processed pseudogenes. Surprisingly, nearly 90% of these inactive genes relate specifically to the genes of keratins 8 and 18. Other keratin genes, as well as those that encode non-keratin IF proteins, lack either gene fragments/pseudogenes or have only a few derivatives. As parasitic derivatives of mature mRNAs, the processed pseudogenes of keratins 8 and 18 have invaded most chromosomes, often at several positions. We describe the limits of our analysis and discuss the striking unevenness of pseudogene derivation in the IF multigene family. Finally, we propose to extend the nomenclature of Moll and colleagues to any novel keratin. INTRODUCTION approach is best exemplified by the pioneering work of Moll and Franke, who in 1982 established the ‘catalog of human cytokeratins’ (Moll et al., 1982). They laid the groundwork for keratin expression profiles and provided a rational nomenclature. Their data were based on the isolation of keratins from microdissected normal and tumor tissues, as separated in high resolution 2D gels. The numbering system for type II keratins ranges from 1 to 8 with letters for later additions and from 9 to 21 for type I keratins. Hair keratins were named in an analogous way with letters Ha and Hb indicating type I and II hair keratins, respectively (Langbein et et al., 1999; Rogers et al., 2000). Subsequent work established that all IF proteins, with the exception of a few polymorphic variants (Mischke and Wild, 1987; Korge et al., 1992), are encoded by single copy genes (Fuchs and Weber, 1994). One difficulty of the classical biochemical and genetic approach is that potential minor keratins and other IF proteins, present in only a few cells of a tissue, or expressed transiently during embryonic development, may have escaped detection. Gene mapping studies revealed that genes coding for nonkeratin IF proteins are not clustered (International Human Genome Sequencing Consortium, 2001). All type I keratin genes (except K18; Waseem et al., 1990) are clustered on chromosome 17q21 and type II genes on 12q13 (International The increase in specific cell types represents one hallmark of metazoan evolution. It is paralleled by the acquisition of multigene families, which often encode proteins of similar structure but distinct function. One such family is represented by the intermediate filament protein (IF) family. Its members form part of the cytoskeleton of most metazoan cells. Vertebrate IF are organised into five distinct gene families according to sequence identity and expression patterns (Fuchs and Weber, 1994; Herrmann and Aebi, 2000). These include keratins (K), which represent the type I and II homology groups encoded by more than 20 genes, and a further 15 hair keratin genes (Langbein et al., 1999; Rogers et al., 2000), the type III proteins desmin, vimentin, GFAP and peripherin, and the type IV homology group, which encompasses α-internexin, syncoilin (Newey et al., 2001), nestin, synemin and the neurofilament proteins NF-L, -M and -H. The nuclear lamins A/C, B1 and B2 form the type V IF, whereas the eye lens proteins phakinin and filensin constitute a separate group. All 16 known non-keratin IF proteins, including syncoilin (Newey et al., 2001) and synemin (Becker et al., 1995; M. Titeux et al., unpublished), were identified by biochemical, immunological and cDNA cloning methods. The power of the classical Key words: Human genome, intermediate filament proteins, keratins, lamins, neurofilament proteins, pseudogenes, disease. 2570 JOURNAL OF CELL SCIENCE 114 (14) IF Gene Fig. 1. Classification and chromosomal localization of intermediate filament genes and pseudogenes. The table lists intermediate filament genes, pseudogenes and gene fragments identified in the draft of the human genome. Keratin genes 8 and 18, which gave rise to 62 and 35 processed pseudogenes, respectively, are marked with a red bar. Potential novel keratin genes/gene fragments in the type I and II clusters are indicated by an asterisk. Chromosomal localization of pseudogenes is indicated by numbers in brackets. Pseudogenes related to hair keratin genes are denoted by ψ; ‡ indicates type I keratin genes recently identified (Bawden et al., 2001). These are most closely related to K10. We propose to name them according to the Moll nomenclature as indicated in the text (Moll et al., 1982). The expression pattern of the newly identified keratin genes remains to be determined. Chromo- # Pseudosome genes # Gene Fragments Type I K9 K10 K10b‡ K10c‡ K10d‡ K12 K12b‡ K13 K14 K15 K16a K17 K18 K19 K20 K23 * 17 17 17 17 17 17 17 17 17 17 17 17 12 17 17 17 17 1 (17) 2 (17) 2 (17) 62 3 (6,15,12) - 1 (17) 2 (17) 15 Hair Type I KRTHA1 KRTHA2 KRTHA3a KRTHA3b KRTHA4 KRTHA5 KRTHA6 KRTHA7 KRTHA8 ψKRTHaA 17 17 17 17 17 17 17 17 17 17 - - Type II K1 K2e k2p K3 K4 K5 K6a K6b K6hf K7 K8 * 12 12 12 12 12 12 12 12 12 12 12 12 1 (12) 35 - 26 1 Human Genome Sequencing Consortium, 2001). Transcription analysis has demonstrated that the diversity of keratins is not increased further by alternative splicing. Knowledge of IF genes and expression patterns stimulated the discovery of point mutations in a still growing number of IF genes, which has provided evidence for their pathogenic relevance in human disorders (Bonifas et al., 1991; Coulombe et al., 1991; Lane et al., 1992; reviewed by Irvine and McLean, 1999). Such ‘experiments of nature’ have demonstrated that mutations in at least 14 epidermal keratin genes cause fragility syndromes of epidermis and its appendages that seem to result from a collapse of a mutant keratin cytoskeleton. Formally, this 2 IF Gene Chromo- # Pseudosome genes # Gene Fragments Hair Type II Hb1 Hb2 Hb3 Hb4 Hb5 Hb6 ψhHbA ψhHbB ψhHbC ψhHbD 12 12 12 12 12 12 12 12 12 12 - - Type III vimentin desmin GFAP peripherin 10 2 17 12 - 1 (6) - Type IV NF-L NF-M NF-H α-Internexin Syncoilin nestin synemin 8 8 22 10 1 1 15 2 (20, 1) - 2 (Y) 1 (10) - Type V lamin A/C laminB1 laminB2 1 5 19 - - Others Filensin Phakinin 20 3 - - Novel Type II keratins K1b K5b K5c K6h K6i K6k K6l 12 12 12 12 12 12 12 - - was the genetic proof for a true cytoskeletal function of these proteins. Desmin mutations analogous to those in epidermal keratins were connected to myopathies of skeletal and heart muscle (Goldfarb et al., 1998), whereas point mutations in GFAP are now known to cause Alexander’s disease (Brenner et al., 2001). At least two reports have linked NF-L mutations to Charcot-Marie-Tooth disease type 2E (Mersiyanova et al., 2000; De Jonghe et al., 2001). Finally, mutations in the genes coding for the nuclear lamins A/C give rise to several tissuerestricted disorders termed laminopathies (for a recent discussion, see Hutchison et al., 2001; Wilson et al., 2001). These data support the view that IF proteins also serve non- Genes for intermediate filament proteins cytoskeletal functions (Quinlan et al., 2001; Wilson et al., 2001). Additional insight into IF protein function comes from genetically altered mice (H. Herrmann et al., unpublished). One common theme that emerges from such studies is that there are essential and nonessential IF protein functions depending on the tissue context. Ablation of keratins leads to extensive tissue fragility in the basal but not in the suprabasal epidermis (Lloyd et al., 1995; Peters et al., 2001; Reichelt et al., 2001). Moreover, knockout studies have demonstrated that certain IF proteins compensate each other (Magin et al., 2000). In addition, the phenotype of some IF gene knockout mice has shed light on new pathologies (Ku et al., 1999; Caulin et al., 2000; Hesse et al., 2000; Tamai et al., 2000). The analysis of diseases with IF involvement as well as the understanding of IF function and evolution will be aided by the knowledge of the corresponding genes. Given that currently about 40 functional keratin genes had been identified, we were surprised by the large number of keratin genes in the recently published draft of the human genome. To clarify whether 111 keratin genes exist in the human genome (International Human Genome Sequencing Consortium, 2001), we have set out to analyze the data-set available in the public domain. 2571 analyses have identified pseudogenes for keratins 8, 14, 16, 17, 18, 19 and hair keratins (Kulesh and Oshima, 1988; Rosenberg et al., 1988; Waseem et al., 1990; Troyanovsky et al., 1992; Ruud et al., 1999; Smith et al., 1999; Hut et al., 2000; Rogers et al., 2000; Winter et al., 2001). The peudogenes coding for K14, K16 and K17, which arose by gene duplication, are located outside the type I keratin cluster. Unexpectedly, processed pseudogenes, which are cDNA derivatives, show a strikingly uneven gene relatedness. By far the highest number of processed pseudogenes relates to keratin genes 8 and 18, which map adjacently on chromosome 12q13 within the type II gene cluster. K8 and K18 are typical of internal epithelia and represent the earliest intermediate RESULTS Number and organisation of keratin genes We have used the NCBI and the Celera genome database for our search and included the most recently published keratins expressed in the inner root sheath (IRS) of hair follicles (Bawden et al., 2001). We found 208 keratin-related sequences in the draft (Fig. 1). Of these, 49 represent single copy genes for type I and II keratins. The type I keratin cluster contains at least 25 functional genes and 2 pseudogenes spread over nearly 1 Mb of DNA; the corresponding type II gene array harbours at least 24 functional genes and 5 pseudogenes distributed along 1.2 to 1.3 Mb. The gene density in the two keratin clusters appears much higher than estimated for the overall genome and is approximately 35 kb per gene. There are 111 pseudogenes plus 47 gene fragments for all keratins. Intron-containing pseudogenes are mostly contained within the two keratin clusters, whereas those with features of processed pseudogenes have invaded most chromosomes, often at several positions (Fig. 2). A few earlier Fig. 2. Chromosomal localization of keratin 8 (A)and 18 pseudogenes (B). Chromosomes numbers are marked in blue. Integration sites per chromosome are marked in red. Coloured bars along chromosomes indicate the integration sites. The extent of sequence identity to K8 and 18 is indicated by red (alignment score >200), blue (alignment score 80-200) and green (alignment score 50-80) bars. 2572 JOURNAL OF CELL SCIENCE 114 (14) K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 1 ~~SRQFSSGS ~~~~~~~~~~ ~MSRQSSVSF ~~~~~~MSLS ~MSRQLNIKS MASTSTTIRS MASTSTTIRS MASTSTTIRS ~MSRQFTCKS ~MSRQLTHFP ~~MRSSVSRQ GYRSGGGFSF ~~~~~~~~~~ RSGGSRSFST PCRAQRGFSA .SGDKGNFSV HSSSRRGFSA HSSSRRGFSA HSSSRRGFSA GAAAKGGFSG .RGERLGFSG TYSTKGGFSS GFAGIINYQR ~~~~~~~~~~ ASAITPSVS. RSACSAR... HSAVVPRKA. SSARLPGVS. NSARLPGVS. NSARLPGVS. CSAVLS.... CSAVLSGGI. NSASGGSGSQ RTTSSSTRRS ~~~~~~~~~~ .RTSFTSVSR ......SRGR ....VGSLAS .RSGFSSISV .RSGFSSISV .RSGFSSISV ....GGSSSS ....GSSSAS ARTSFSSVTV 50 GGGGGRFSSS ~~~~~~~~~~ SGGGGGGGFG SRGGFSS... YCAAGRG... SRSRGSG... SRSRGSG... SRSRGSG... FRAGSKG... FRAR...... SRSSGSGG.. K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 51 GGGGGSFGAG ~~~~~~~~~~ RVSLAGACGV .........R ........AG ..GLGGACGG ..GLGGACGG ..GLGGACGG ........LS .......... ..GAHCGPGT GGFGSRSLAG ~~MG.RSTSG GGYGSRSLYN GGFSSRSLNS AGFGSRSLYS AGFGSRSLYG AGFGSRSLYG AGFGSRSLYG GGFGSRSLYS .......... GGFGSRSLYN SGGSIASISG .........F LGG....... FGR....... LGG....... LGG....... LGG....... LGG....... LGG....... .......... LGG....... ARGGGGGSGF CQGGGVG.GF ..SKRISIST ...CLEG... ..NRRISFNV ..SKRISIGG ..SKRISIGG ..SKRISIGG ..VR..SLNV .......... ..HKSISVSV 100 GGGYG.GGGF GGGR....GF RGGSF.RNRF SRGS...... AGGGVRAGGY GSCAI.SGGY GSCAI.SGGY GSCAI.SGGY ASGSGKSGGY .......... AGGAL.SG.. K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 101 GGGGFGGGGF GVGSTGAGGF GAGAGGGYGF ......TWGS GFRPGSGYGG GSRAGAGYGF GSRAGGSYGF GSRAGGSYGF GFG......R .......... .......RAL GGGGIGGGGF GGG....... GGG.....AG G......... GRA....... GG......AG GG......AG GG......AG GRA....... .......... GG........ GGFGSGGGGF .GFG..GAGF SGFGFGGGAG ...GRLGVRF ..SGFAGSMF SGFGFGGGAG SGFGFGGGAG SGFGFGGGAG ..SGFAGSMF .......... ..FGFGSRAF GGGGFGGGG. GTSNFGLG.. GGFGLGGGAG GEWSGGPG.. GSVALGPAC. IGFGLGGGP. IGFGLGGGAG IGFGLGGGAG GSVALGPVC. .......... MGQGAGRQT. 150 ...GYGGGYG .......GFG FGGGFGGPGF .........L ....L..... ALLCFGGPGF LAGGFGGPGF LAGGFGGPGF ....P..... .......... ....FG.... K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 151 PVCSPGGIQE PYCPPGGIQE PVCPPGGIQE SLCPPGGIQE SVCPPGGIHQ PVCPPGGIQE PVCPPGGIQE PVCPPGGIQE TVCPPGGIHQ .......... PACPPGGIQE VTINQSLLQP VTINQSLLEP VTVNQSLLTP VTINQNLLTP VTVNKSLLAP VTVNQSLLTP VTVNQSLLTP VTVNQSLLTP VTVNESLLAP VTVNKSLLAP VTVNQSLLTP LNVEIDPEIQ LHLEVDPEIQ LNLQIDPSIQ LKIEIDPQFQ LNVELDPEIQ LNLQIDPAIQ LNLQIDPAIQ LNLQIDPAIQ LNVELDPEIQ LNVEMDPEIQ LHVEIDPEIQ Coil 1A 200 KVKSREREQI QSLNNQFASF RIKTQEREQI MVLNNKFASF RVRTEEREQI KTLNNKFASF VVRTQETQEI RTLNNQFASF KVRAQEREQI KVLNDKFASF RIGAEEREQI KTLNNKFASF RVRAEEREQI KTLNNKFASF RVRAEEREQI KTLNNKFASF KVRAQEREQI KALNNKFASF RVRAQEREQI KALNNKFASF RVRTQEREQI KTLNNKFASF K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 201 IDKVRFLEQQ IDKVQFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ IDKVRFLEQQ NQVLQTKWEL NQVLQTKWEL NKVLDTKWTL NKVLETKWHL NQVLETKWEL NKVLDTKWTL NKVLDTKWTL NKVLDTKWTL NQVLETKWEL NQVLETKWNL NKVLETKWAL LQQVD..TST LQQVN..TST LQEQG..TKT LQQQG..LSG LQQLD..LNN LQEQG..TKT LQEQG..TKT LQEQG..TKT LQQLD..LNN LQQLD..LNN LQEQGQNLGV RTHNLEPYFE GTNNLEPLLE VRQNLEPLFE SQQGLEPVFE CKKNLEPILE VRQNLEPLFE VRQNLEPLFE VRQNLEPLFE CKNNLEPILE CRKNLEPIYE TRNNLEPLFE K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 251 DQLKSDQSRL DLLSAEQMRQ DSIVGERGRL EQLQGERGAL ETLSGDRVRL DSIVGERGRL DNIVGERGRL DSIVGERGRL ETLSGDRVRL EMLSGDGVRL DRLQSERGRL DSELKNMQDM NAEVRSMQDV DSELRNMQDL DAELKACRDQ DSELRSMRDL DSELRNMQDL DSELRNMQDL DSELRNMQDL DSELRNVRDV DSELRNMQDL DSELRNVQDL VEDYRNK... VEDYKSK... VEDFKNK... EEEYKSK... VEDYKKR... VEDLKNK... VEDLKNK... VEDLKNK... VEDYKKR... VEDYKNKKKQ VEDFKNK... Coil 1B 300 ..YEDEINKR TNAENEFVTI ..YEDEINKR TGSENDFVVL ..YEDEINKR TTAENEFVML ..YEEEAHRR ATLENDFVVL ..YEVEINRR TTAENEFVVL ..YEVEINKR TAAENEFVTL ..YEDEINKR TAAENEFVTL ..YEDEINKR TAAENEFVTL ..YEEEINKR TAAENEFVLL IWYEVEINRR TAAENEFVVL ..YEDEINKH TAAENEFVVL K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 301 KKDVDGAYMT KKDVDAAYVS KKDVDAAYMN KKDVDAVFLS KKDADAAYAV KKDVDAAYMN KKDVDAAYMN KKDVDAAYMN KKDVDAAYAN KKDVDAAYMN KKDVDAAYMG KVDLQAKLDN KVDLESRVDT KVELEAKVDA KMELEGKLEA KVELQAKVDS KVELQAKADT KVELQAKADT KVELQAKADT KVELQAKVES KVELQAKVDS RMDLHGKVGT LQQEIDFLTA LTGEVNFLKY LMDEINFMKM LREYLYFLKH LDKDIKFLKC LTDEINFLRA LTDEINFLRA LTDEINFLRA MDQEIKFFRC LTDEIKFFKC LTQEIDFLQQ LY...QAELS LF...LTELS FF...DAELS LN...EEELG LY...DAEIA LY...DAELS LY...DAELS LY...DAELS LF...EAEIT LY...EGEIT LYEMHDAELS 350 QMQTQISETN QVQTHISDTN QMQTHVSDTS QLQTQASDTS QIQTHASETS QMQTHISDTS QMQTHISDTS QMQTHISDTS QIQSHISDMS QIQSHISDTS QVQTHVSNTN K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 351 VILSMDNNRQ VILFMDNNRS VVLSMDNNRN VVLSMDNNRY VILSMDNNRD VVLSMDNNRN VVLSMDNNRN VVLSMDNNRN VILSMDNNRN IVLSMDNNRD VVLSMDNNRN FDLDSIIAEV LDLDSIIDAV LDLDSIIAEV LDFSSIITEV LDLDSIIAEV LDLDSIIAEV LDLDSIIAEV LDLDSIIAEV LDLDSIIDEV LDLDSIIAEV LDLDSIIAEV Coil KAQNEDIAQK RTQYELIAQR KAQYEEIANR RARYEEIARS RMHYEEIALK KAQYEEIAQR KAQYEEIAQR KAQYEEIAQR RTQYEEIALK RAQYEEIALK KAQYELIAQR 2A SKAEAESLYQ SKDEAEALYQ SRTEAESWYQ SKAEAEALYQ SKAEAEALYQ SRAEAESWYQ SRAEAESWYQ SRAEAESWYQ SKAEAEALYQ SKAEAETLYQ SRAEAEAWYQ 400 SKYEELQITA TKYQELQITA TKYEELQQTA TKVQELQVSA TKIQELQLAA TKYEELQVTA TKYEELQITA TKYEELQVTA TKFQELQLAA TKIQELQVTA TKYEELQVTA 401 K1 K1b K5 _ 450 GRHGDSVRNS KIEISELNRV IQRLRSEIDN VKKQISNLQQ SISDAEQRGE GRHGDDLKNS KMEIAELNRT VQRLQAEISN VKKQIEQMQS LISDAEERGE GRHGDDLRNT KHEITEMNRM IQRLRAEIDN VKKQCANLQN AIADAEQRGE 250 SFINNLRRGV NYIGDLRRQV QYINNLRRQL ACLDQLRKQL GYISNLRKQL QYINNLRRQL QYINNLRRQL QYINNLRRQL GYISNLRKQL GYISNLQKQL AYLGSMRSTL K5b K5c K6a K6b K6h K6i K6k K6l QLHGDRMQET SRHGDDLKHT GRHGDDLRNT GRHGDDLRNT GRHGDDLRNT GRHGDDLKNT GQHGDDLKLT GKHGDNLRDT KVQISQLHQE RSEMVELNRL KQEIAEINRM KQEIAEINRM KQEIAEINRM KNEISELTRL KAEISELNRL KNEIAELTRT IQRLQSQTEN IQRIRCEIGN IQRLRSEIDH IQRLRSEIDH IQRLRSEIDH IQRIRSEIEN IQRIRSEIGN IQRLQGEADA LKKQNASLQA VKKQRASLET VKKQCANLQA VKKQCANLQA VKKQCASLQA VKKQASNLET VKKQCADLET AKKQCQQLQT AITDAEQRGE AIADAEQRGD AIADAEQRGE AIADAEQRGE AIADAEQRGE AIADAEQRGD AIADAEQRGD AIAEAEQRGE K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 451 NALKDAKNKL QALQDAWQKL LALKDARNKL LALKDAQAKV NALKDAQAKL MALKDAKNKL MALKDAKNKL MALKDAKNKL NALKDARAKL CALKDARAKL LALKDAQKKL Coil NDLEDALQQA QDLEEALQQS AELEEALQKA DELEAALRMA DELEGALHQA EGLEDALQKA EGLEDALQKA EGLEDALQKA DELEGALHQA DELEGALHQA GDLDVALHQA 2B KEDLTRLLRD KEELARLLRD KQDMARLLRE KQNLARLLCE KEELARMLRE KQDLARLLKE KQDLARLLKE KQDLARLLKE KEELARMLRE KEELARMLRE KEDLTRLLRD YQELMNTKLA YQAMLGVKLS YQELMNTKLA YQELTSTKLS YQELMSLKLA YQELMNVKLA YQELMNVKLA YQELMNVKLA YQELMSLKLA YQELVSLKLA YQELMNVKLA 500 LDLEIATYRT LDVEIATYRQ LDVEIATYRK LDVEIATYRR LDMEIATYRK LDVEIATYRK LDVEIATYRK LDVEIATYRK LDMEIATYRK LDMEIATYRK LDVEIATYRK K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 501 LLEGEESRMS LLEGEESRMS LLEGEECRLS LLEGEECRMS LLEGEECRMS LLEGEECRLN LLEGEECRLN LLEGEECRLN LLESEECRSR LLESEECRMS LLESEESRMS GECAPNVSVT GELQSHVSIS GEGVGPVNIS GECTSQVTIS GENPSSVSIS GEGVGQVNIS GEGVGQVNIS GEGVGQVNVS .........S GEYPNSVSIS GECPSAVSIS VSTSHTSISG VQNSQVSVNG VVTSSVSSGY SVGGSAVMSG VIS.SSSYSY VVQSTVSSGY VVQSTVSSGY VVQSTISSGY SG........ VIS.STN... VTGNSTTVCG GGSRGGGGGG G...AGGGGS G.....SGSG G...VGGGLG H...HPSSAG G.....GASG G.....GASG G.....GASG ....HPTGGC A...GAGGAG G.....GAAS 550 YGSGGSSYGS YGSGG..YG. YGGGLGGGLG STCGLG.... VDLGAS.... VGSGLG.... VGSGLG.... VGSGLG.... LQQSKP.... FSMGFG.... FGGGIS.... K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 551 GGGSYGSGGG .GG...SGGG GGLGGGLAGG ......SGKG .....AVAGS ......LGGG ......LGGG ......LGGG .....DTAAQ .....ASSSY ......LG.G GGGGRGSYGS YGGGR.SYR. SSGSY..YSS SPG....... SGS....... SS........ SS........ SS........ RG........ SYK....... SG........ GGGSYGSGGS GGGARGR... SSGGVGL... .....S.... .......... ....YSY... ....YSY... ....YSY... .......... .......... .......... SYGSGGGGGG ...SGGG... .......... .......... .......... .......... .......... .......... .......... .......... .......... 600 HGSYGSGSSS ...YGSG... .......... .......... .......... .......... .......... .......... .......... .......... .......... K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 601 GGYRGGSGGG .......CGG .....G.... ........CC .......... .....G.... .....G.... .....G.... .......... .......... .......... GGGSSGGRGS GGGSYGG... GGLSVGGSGF TSIVTGGSNI ..TQSGQTKT SGLGVGG.GF SGLGVGG.GF SGLGIGG.GF ..NHQGLLGV ..TAAADVKT .GATKGG..F GGGSSGGSSG .SGRS..... SASSGRGLGV ILGSGKDPVL TEARGGDLKD SSSSGRATGG SSSSGRATGG SSSSGRAIGG KPAVDME~~~ KGSCGSELKD STNVGYSTVK GRGSSSGGVK GRGSSR..VQ GFGSGGGSSS DSCSVSGSSA TQGKSTPASI GLSSVGGGSS GLSSVGGGSS GLSSVGGGSS ~~~~~~~~~~ PLAKTSGSSC G.GPVSAGTS 650 SSGGSSSVKF IIQTST.... SVKFVSTT.. GSSCHTILKK PARKATR~~~ TIKYTTTS.. TIKYTTTS.. TIKYTTTS.. ~~~~~~~~~~ ATKKASR~~~ ILRKTTTV.. K1 K1b K5 K5b K5c K6a K6b K6h K6i K6k K6l 651 662 VSTTYSGVTR ~~ .NTSHRRILE ~~ .SSSRKSFKS ~~ TVESSLKTSI TY ~~~~~~~~~~ ~~ .SSSRKSYKH ~~ .SSSRKSYKH ~~ .SSSRKSYKH ~~ ~~~~~~~~~~ ~~ ~~~~~~~~~~ ~~ .KTSSQRY~~ ~~ Fig. 3. Comparison of type II keratins identified in this study. An alignment of the type II keratin sequences is given in the single letter code (residue numbers on top) with gaps introduced to maximize the amino acid alignment (dashes). Ends of the α-helical subdomains of the rod (1A, 1B, 2A and 2B) are indicated by solid arrowheads. For comparison, sequences of human keratins 1 and 5, the closest relatives, are co-aligned. For K6i, a different C-terminal sequence has been determined (M. Rogers, personal communication). Starting from position 443, it reads MSGEFPSPVS ISIISSTSGG SVYGFRPSMV SGGYVANS SNCISGVCSV RGGEGRSRGS ANDYKDTLGK GSSLSAPSKK TSR*. Asterisk indicates termination codon. Genes for intermediate filament proteins A 2573 B Fig. 4. Phylogenetic relationship of the human type I and II keratins. The phylogenetic tree shown was generated following the alignment of human type I (A) and type II keratins (B). Multiple sequence alignments were performed using the CLUSTAL program. Evolutionary tree construction was prepared using the CLUSTREE program. For the alignment, sequences published in the human genome draft were used (International Human Genome Sequencing Consortium, 2001). filament expression pair in embryogenesis. There are 62 processed pseudogenes plus 15 gene fragments for the keratin 18 gene, and 35 processed pseudogenes plus 26 gene fragments for the keratin 8 gene (for a previous notion of pseudogenes, see Kulesh and Oshima, 1988; Waseem et al., 1990). These processed pseudogenes are dispersed over all chromosomes (see Fig. 2). None of these pseudogenes contained an intact open reading frame. Other keratin genes are either true single copy genes or are accompanied by one to four pseudogenes (Fig. 1). In the present draft, no gene for keratin 11 (Moll et al., 1982), which may represent a polymorphic variant of K10 (Mischke and Wild, 1987; Korge et al., 1992) or for K6c-f (Takahashi et al., 1995) were found. The status of the latter may have to await the completion of the human genome. Novel keratin genes and nomenclature We discovered seven new type II keratins. Of these, five displayed homology to K6a, K6b and K5, one was most closely related to K1 and one was highly similar to K6b (Fig. 3). This new member of the K6 family has 99% protein sequence identity to K6b, but at the genomic level it contains a completely different intron 3. The evolutionary relationship of keratins is outlined in Fig. 4. Owing to the incomplete alignment of contigs, a few additional keratin genes and pseudogenes may exist. The total number of keratin genes amounts to 49. Our survey of the current draft of the human genome conforms well with the view of 22 keratins expressed in various epithelia, 15 trichocyte-specific, 5 inner root sheath and 7 novel keratins described in this report. Together with the 13 genes for the nonkeratin IF proteins, the number of genes encoding cytoplasmic IF proteins reaches 62. The three nuclear lamin genes bring the entire IF multigene family to 65. Based on the numbering system introduced by Moll and colleagues (Moll et al., 1982), we propose to name novel type II keratins according to their sequence relationship with one of the existing eight type II genes, followed by a small letter. The 2574 JOURNAL OF CELL SCIENCE 114 (14) type II keratin genes reported in this study are therefore named K1b, K5b, K5c, K6h, K6i, K6k and K6l. Type I keratins should be named in the same way (see also Fig. 1). Novel genes not related to existing proteins should be given new numbers starting with K21. Non-keratin IF genes All 13 genes encoding the non-keratin cytoplasmic IF proteins are covered by the draft sequence (Fig. 1). Given the considerable sequence drift among these genes, the chicken sequence of synemin was non-informative for the identification of human synemin. The human orthologue was identified by D. Paulin (M. Titeux et al., unpublished). No additional functional IF gene was recognized in the current draft. Interestingly, pseudogenes are very rare among the nonkeratin genes. Only the neurofilament NF-H gene is accompanied by two pseudogenes. Also, the genes for the three nuclear lamins (lamins A/C, B1 and B2) lack pseudogenes. If the completed version of the human genome lacks an additional lamin gene, the oocyte-specific lamin of certain amphibia (Döring and Stick, 1990) has no orthologue in the human genome. CONCLUSIONS AND PERSPECTIVES Our analysis is limited by two factors: (1) the alignment of contigs leading to the present draft is still incomplete; therefore, we cannot exclude the existence of a few more keratin genes. In light of the fidelity of the ‘Moll catalog’ and the concordant phenotypes of keratin-knockout mice (H. Herrmann et al., unpublished), we predict that any keratins yet to be discovered may be restricted to the hair follicle and/or other epidermal appendages. The existence of additional keratins specific for embryonic stages or specialized cells of internal epithelia appears unlikely. (2) Given the strong sequence drift among non-keratin IF genes, novel IF genes with yet unknown properties might exist. The prototype of such proteins could be represented by syncoilin, a constituent IF member of the dystrobrevin complex, which was proposed to link IF proteins to dystrobrevin at the neuromuscular junction (Newey et al., 2001). One task ahead will be to determine whether syncoilin does form copolymers with muscle-specific IF proteins or whether it serves different functions. In view of the well-conserved structure of IF proteins and the common principles governing their assembly properties, a search for mutations in known and newly discovered IF protein genes is likely to reveal their involvement in additional disorders and to unravel new IF functions (see also Quinlan, 2001). Most vertebrate gene families have pseudogenes, but these usually represent only a small minority of the total gene number (Mighell et al., 2000). Thus, the large number of pseudogenes for the keratin gene family is startling. Particularly striking is the finding that some 87% of these pseudogenes relate to keratin genes 8 and 18. An uneven distribution also holds for the human actin pseudogenes. There are 23 pseudogenes for β- and 6 for γ-cytoplasmic actin, while the four muscle actin genes lack pseudogenes (Pollard, 2001). The molecular mechanisms resulting in the generation of pseudogenes from some but not other genes are unknown. However, a future analysis of their integration sites may yield further information about the structural properties of human chromatin and the mechanisms of recombination. We are grateful to D. Paulin (Paris) for providing the human synemin gene sequence, and to J. Schweizer and M. Rogers (Heidelberg) for helpful discussion and for providing sequence information on K6i. We also thank D. Siepe (Bonn) for advice on database searches. This work was supported by the DFG (SFB 284, C7) to T.M.M. Note added in proof While this manuscript was under review, Mizuno et al. characterized desmuslin, an IF protein that interacts with αdystrobrevin and desmin (Mizuno et al., 2001). When we compared its sequence with that of human synemin, we found it to be nearly identical to the synemin α splice variant described by M. Titeux et al. (unpublished). Therefore, we propose to use the established name synemin. REFERENCES Bawden, C. S., McLaughlan, C., Nesci, A. and Rogers, G. (2001). A unique type I keratin intermediate filament gene family is abundantly expressed in the inner root sheaths of sheep and human hair follicles. J. Invest. Dermatol. 116, 157-166. Becker, B., Bellin, R. M., Sernett, S. W., Huiatt, T. W. and Robson R. M. (1995). Synemin contains the rod domain of intermediate filaments. Biochem. Biophys. Res. Commun. 213, 796-802. Bonifas, J. M., Rothman, A. L. and Epstein, E. H. (1991). Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 254, 1202-1205. Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E. and Messing, A. (2001). Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27, 117-120. Caulin, C., Ware, C. F., Magin, T. M. and Oshima. R. G. (2000). Keratindependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149, 17-22. Coulombe, P. A., Hutton, M. E. Letai, A., Hebert, A., Paller, A. S. and Fuchs, E. (1991). Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 66, 1301-1311. De Jonghe, P., Mersivanova, I. Nelis, E., Del Favero, J., Martin, J. J., Van Broeckhoven, C., Evgrafov, O. and Timmerman, V. (2001). Further evidence that neurofilament light chain gene mutations can cause CharcotMarie-Tooth disease type 2E. Ann. Neurol. 49, 245-249. Doring, V. and Stick, R. (1990). Gene structure of nuclear lamin LIII of Xenopus laevis; a model for the evolution of IF proteins from a lamin-like ancestor. EMBO J. 9, 4073-4081. Fuchs, E. and Weber, K. (1994). Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem 63, 345-382. Goldfarb, L. G., Park, K. Y., Cervenakova, L., Gorokhova, S., Lee, H. S., Vasconcelos, O., Nagle, J. W., Semino-Mora, C., Sivakumar, K. and Dalakas, M. C. (1998). Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet. 19, 402-403. Herrmann, H. and Aebi, U. (2000). Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12, 79-90. Hesse, M., Franz, T., Tamai, Y., Taketo, M. M. and Magin, T. M. (2000). Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality. EMBO J. 19, 5060-5070. Hut, P. H., Vlies, P., Jonkman, M. F., Verlind, E., Shimizu, H., Buys, C. H. and Scheffer, H. (2000). Exempting homologous pseudogene sequences from polymerase chain reaction amplification allows genomic keratin 14 hotspot mutation analysis. J. Invest Dermatol. 114, 616-619. Hutchison, C. J., Alvarez-Reyes, M. and Vaughan, O. A. (2001). Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J. Cell Sci. 114, 9-19. Genes for intermediate filament proteins International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. Irvine, A. D. and McLean, W. H. (1999). Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br. J. Dermatol. 140, 815-828. Korge, B. P., Gan, S. Q., McBride, O. W., Mischke, D. and Steinert, P. M. (1992). Extensive size polymorphism of the human keratin 10 chain resides in the C-terminal V2 subdomain due to variable numbers and sizes of glycine loops. Proc. Natl. Acad. Sci. USA 89, 910-914. Ku, N. O., Zhou, X., Toivola, D. M. and Omary, M. B. (1999). The cytoskeleton of digestive epithelia in health and disease. Am. J. Physiol. 277, G1108-G1137. Kulesh, D. A. and Oshima, R. G. (1988). Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol. Cell Biol. 8, 15401550. Lane, E. B., Rugg, E. L., Navsaria, H., Leigh, I. M., Heagerty, A. H., Ishida, Y. A. and Eady, R. A. (1992). A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 356, 244-246. Langbein, L., Rogers, M. A., Winter, H., Praetzel, S., Beckhaus, U., Rackwitz, H. R. and Schweizer, J. (1999). The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. J. Biol. Chem. 274, 19874-19884. Lloyd, C., Yu, Q. C., Cheng, J., Turksen, K., Degenstein, Hutton, L. E. and Fuchs, E. (1995). The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol. 129, 1329-1344. Magin, T. M., Hesse, M. and Schroder, R. (2000). Novel insights into intermediate-filament function from studies of transgenic and knockout mice. Protoplasma 211, 140-150. Mersiyanova, I. V., Perepelov, A. V., Polyakov, A. V., Sitnikov, V. F., Dadali, E. L., Oparin, R. B., Petrin, A. N. and Evgrafov, O. V. (2000). A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67, 37-46. Mighell, A. J., Smith, N. R., Robinson, P. A. and Markham, A. F. (2000). Vertebrate pseudogenes. FEBS Lett. 468, 109-114. Mischke, D. and Wild, G. (1987). Polymorphic keratins in human epidermis. J. Invest. Dermatol. 88, 191-197. Mizuno, Y., Thompson, T. G., Guyon, J. R., Lidov, H. G., Brosius, M., Imamura, M., Ozawa, E., Watkins, S. C. and Kunkel, L. M. (2001). Desmuslin, an intermediate filament protein that interacts with alphadystrobrevin and desmin. Proc. Natl. Acad. Sci. USA 98, 6156-6161. Moll, R., Franke, W. W., Schiller, D. L., Geiger, B. and Krepler, R. (1982). The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11-24. Newey, S. E., Howman, E. V., Ponting, C. P., Benson, M. A., Nawrotzki, 2575 R., Loh, N. Y., Davies, K. E. and Blake D. J. (2001). Syncoilin, a novel member of the intermediate filament superfamily that interacts with alphadystrobrevin in skeletal muscle. J. Biol. Chem. 276, 6645-6655. Peters, B., Kirfel, J., Büssow, H., Vidal, M. and Magin, T. M. (2001) Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in EBS. Mol. Biol. Cell (in press). Pollard, T. D. (2001). Genomics, the cytoskeleton and motility. Nature 409, 842-843. Quinlan, R. (2001). Cytoskeletal catastrophe causes brain degeneration. Nat. Genet. 27, 10-11. Reichelt, J., Büssow, H., Grund, C. and Magin, T. M. (2001). Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol. Biol. Cell (in press). Rogers, M. A., Winter, H., Langbein, L., Wolf, C. and Schweizer, J. (2000). Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. J. Invest Dermatol. 114, 464-472. Rosenberg, M., RayChaudhury, A., Shows, T. B., Le, B. M. and Fuchs, E. (1988). A group of type I keratin genes on human chromosome 17: characterization and expression. Mol. Cell Biol 8, 722-736. Ruud, P., Fodstad, O. and Hovig, E. (1999). Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptasepolymerase chain reaction assays used to detect micrometastatic tumor cells. Int. J. Cancer 80, 119-125. Smith, F. J., McKusick, V. A., Nielsen, K., Pfendner, E., Uitto, J. and McLean, W. H. (1999). Cloning of multiple keratin 16 genes facilitates prenatal diagnosis of pachyonychia congenita type 1. Prenat. Diagn. 19, 941-946. Tamai, Y., Ishikawa, T., Bosl, M. R., Mori, M., Nozaki, M., Baribault, H., Oshima, R. G. and Taketo, M. M. (2000). Cytokeratins 8 and 19 in the mouse placental development. J. Cell Biol. 151, 563-572. Takahashi, K., Paladini, R. D. and Coulombe, P. A. (1995). Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J. Biol. Chem. 270, 18581-18592. Troyanovsky, S. M., Leube, R. E. and Franke, W. W. (1992). Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur. J. Cell Biol. 59, 127-137. Waseem, A., Gough, A. C., Spurr, N. K. and Lane, E. B. (1990). Localization of the gene for human simple epithelial keratin 18 to chromosome 12 using polymerase chain reaction. Genomics 7, 188-194. Winter, H., Langbein, L., Krawczak, M., Cooper, D. N., Jave-Suarez, L. F., Rogers, M. A., Praetzel, S., Heidt, P. J. and Schweizer, J. (2001). Human type I hair keratin pseudogene phihHaA has functional orthologs in the chimpanzee and gorilla: evidence for recent inactivation of the human gene after the Pan-Homo divergence. Hum. Genet. 108, 37-42. Wilson, K. L., Zastrow, M. S. and Lee, K. K. (2001). Lamins and disease: insights into nuclear infrastructure. Cell 104, 647-650.

Helpful advice for finalizing your ‘Tender Authorization Letter Sample’ online

Are you weary of the inconvenience of managing documentation? Look no further than airSlate SignNow, the premier electronic signature platform for individuals and businesses. Bid farewell to the tedious process of printing and scanning documents. With airSlate SignNow, you can effortlessly finalize and sign documents online. Utilize the powerful features embedded in this user-friendly and cost-effective platform to transform your document handling practices. Whether you need to sign forms or gather eSignatures, airSlate SignNow simplifies the process with just a few clicks.

Adhere to this comprehensive guide:

  1. Access your account or register for a complimentary trial of our service.
  2. Select +Create to upload a document from your device, cloud storage, or our template library.
  3. Open your ‘Tender Authorization Letter Sample’ in the editor.
  4. Select Me (Fill Out Now) to complete the form on your end.
  5. Add and assign fillable fields for other participants (if required).
  6. Proceed with the Send Invite settings to request eSignatures from others.
  7. Download, print your copy, or convert it into a reusable template.

No need to worry if you wish to collaborate with your colleagues on your Tender Authorization Letter Sample or submit it for notarization—our solution offers everything you need to accomplish such tasks. Sign up with airSlate SignNow today and elevate your document management to a new standard!

Here is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Need help? Contact Support
Tender authorization letter sample word format
Tender authorization letter sample pdf
Manufacturer Authorization letter for tender
Tender authorization letter sample doc
Sample letter of authorization giving permission
Sample letter of authorization giving permission on my behalf
Sign up and try Tender authorization letter sample form
  • Close deals faster
  • Improve productivity
  • Delight customers
  • Increase revenue
  • Save time & money
  • Reduce payment cycles